Acute and maintenance treatment with mood stabilizers

International Journal of Neuropsychopharmacology

Volumn 6, Issue 3, 2003, Pages 269-275

  Bowden, Charles L ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Bipolar disorder; Lamotrigine; Lithium; Mania; Valproate

Indexed keywords

CARBAMAZEPINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; OLANZAPINE; RISPERIDONE; VALPROATE SEMISODIUM; VALPROIC ACID;

BIPOLAR DISORDER; CLINICAL TRIAL; DEPRESSION; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; MANIA; MONOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RELAPSE; REVIEW; SYMPTOMATOLOGY;

ANTIMANIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; HUMANS;

EID: 0141961735     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145703003535     Document Type: Review

References (31)

1. Altman EG, Hedeker DR, Janicak PG, Peterson JL, Davis JM (1994). The Clinician-Administered Rating Scale for Mania (CARS-M): development, reliability, and validity. Society of Biological Psychiatry 36, 124-134.
2. Bowden C, Calabrese J, Sachs G, Evoniuk G, Metz A (2003). Concomitant use of lamotrigine and valproate in bipolar I disorder. Presented at the Annual Meeting of the (NCDEU). Boca Raton, Florida, May.
3. Bowden CL (1995). Predictors of response to divalproex and lithium. Journal of Clinical Psychiatry 56, 25-30.
4. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza-Trevino ES, Risch SC, Goodnick PJ, Morris DD (1994). Efficacy of divalproex vs lithium and placebo in the treatment of mania. Journal of the American Medical Association 271, 918-924.
5. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope Jr. HG, Chou JC-Y, Keck Jr. PE, Rhodes LJ, Swann AC, Hirschfeld RMA, Wozniak PJ (2000). A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Archives of General Psychiatry 57, 481-489.
6. Bowden CL, Calabrese JR, McElroy SL, Rhodes LJ, Keck Jr. PE, Cookson J, Anderson J, Bolden-Watson C, Ascher J, Monaghan E, Zhou J (1999). The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biological Psychiatry 45, 953-958.
7. Bowden CL, Calabrese JR, Sachs G, Swann A, Akthar S, DeVeaugh-Geiss J (In Press). A randomized, placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Archives of General Psychiatry 60, 392-400.
8. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd DG (1999). A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Journal of Clinical Psychiatry 60, 79-88.
9. Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM (1997). Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. Journal of Clinical Psychiatry 58, 470-478.
10. Dunner DL, Stallone F, Fieve RR (1976). Lithium carbonate and affective disorders V: a double-blind study of prophylaxis of depression in bipolar illness. Archives of General Psychiatry 33, 117-120.
11. Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA, Cora-Locatelli G, Leverich GS, Post RM (2000). A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. Journal of Clinical Psychopharmacology 20, 607-614.
12. Gitlin MJ, Swendsen J, Heller TL, Hammen C (1995). Relapse and impairment in bipolar disorder. American Journal of Psychiatry 152, 1635-1640.
13. Greil W, Kleindienst N (1999a). Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Int Clin Psychopharmacol 14(5): 283-285.
14. Greil W, Kleindienst N (1999b). The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Int Clin Psychopharmacol 14(5): 277-281.
15. Greil W, Kleindienst N, Erazo N, Müller-Oerlinghausen B (1998). Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. Journal of Clinical Psychopharmacology 18, 455-460.
16. Grunze H, Erfurth A, Marcuse A, Amann B, Normann C, Walden J (1999). Tiagabine appears not to be efficacious in acute mania. Journal of Clinical Psychiatry 60, 759-762.
17. Hirschfeld RMA, Bowden CL, Gitlin MJ, Keck PE, Suppes T, Thase ME (2002). Practice guideline for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry 159, 1-50.
18. Hirschfeld R, Weisler R, Keck Jr. P, Ahern E, Revicki D (1999). Cost-effectiveness evaluation of divalproex sodium vs. lithium in the treatment of bipolar disorder. Proceedings of the 1999 American Psychiatric Association Annual Meeting. Washington, DC.
19. Johnson RE, McFarland BH (1996). Lithium use and discontinuation in a health maintenance organization. American Journal of Psychiatry 153, 993-1000.
20. Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S (1987). Carbamazepine versus lithium in mania: a double-blind study. Journal of Clinical Psychiatry 48, 89-93.
21. Miklowitz DJ, Goldstein MJ (1990). Behavioral family treatment for patients with bipolar affective disorder. Behavior Modification 14, 457-489.
22. Miklowitz DJ, Simoneau TL, George EL, Richards JA, Kalbag A, Sachs-Ericsson N, Suddath R (2000). Family focused treatment of bipolar disorder: 1-Year effects of a psychoeducational program in conjunction with pharmacotherapy. Biological Psychiatry 48, 582-592.
23. Muller-Oerlinghausen B, Retzow A, Henn FA, Giedke H, Walden J (2000). Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. Journal of Clinical Psychopharmacology 20, 195-203.
24. Sachs G, Grossman F, Okamoto A, Ghaemi SN, Bowden CL (2002). Risperidone plus mood stabilizer versus placebo plus mood stabilizer for actue mania of bipolar disorder: a double-blind comparison of efficacy and safety. American Journal of Psychiatry 159, 1146-1154.
25. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP (2000). The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder. McGraw-Hill Companies: A Postgraduate Medicine Special Report, 2000.
26. Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J, Dilsaver SC, Davis JM (1997). Depression during mania: treatment response to lithium or divalproex. Archives of General Psychiatry 54, 37-42.
27. Suppes XX, Bowden CL, Mitchell P, Suppes T (1999). Lamotrigine in the treatment of bipolar depression. European Neuropsychopharmacology 000, 000-000.
28. Tohen M, Chengappa KNR, Suppes T, Zarate CA JR, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A (2002). Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry 59, 62-69.
29. Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A (2000). Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Archives of General Psychiatry 57, 841-849.
30. Vasudev K, Goswami U, Kohli K (2000). Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Psychopharmacology 150, 15-23.
31. Yatham L (2000). Safety and efficacy of risperidone as combination therapy for the manic phase of bipolar disorder: preliminary findings of a randomized, double-blind study [Abstract]. Presented at the 13th European College of Neuropsychopharmacology Congress, Munich, Germany, September 2000.